Clinical Trial Update: Effect of ASV and DCV Therapy on the Quality of Immune Status in Chronic HCV Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating asunaprevir and daclatasvir on immune status in chronic hepatitis C patients has completed, with an update on immune-related o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Asunaprevir (asunaprevir)
• Daclatasvir (daclatasvir)

Snippet

Sponsor: Foundation for Liver Research | Conditions: Chronic Hepatitis C | Phase 3 | Status: COMPLETED